Compare ENPH & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENPH | SHC |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.4B |
| IPO Year | 2011 | 2020 |
| Metric | ENPH | SHC |
|---|---|---|
| Price | $63.74 | $15.54 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 23 | 7 |
| Target Price | ★ $41.30 | $20.33 |
| AVG Volume (30 Days) | ★ 8.8M | 4.0M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.00 | 68.75 |
| EPS | N/A | ★ 0.09 |
| Revenue | ★ $1,472,985,000.00 | $1,163,617,000.00 |
| Revenue This Year | N/A | $7.51 |
| Revenue Next Year | $9.81 | $6.00 |
| P/E Ratio | ★ N/A | $173.94 |
| Revenue Growth | ★ 10.72 | 5.74 |
| 52 Week Low | $25.78 | $10.80 |
| 52 Week High | $73.74 | $19.85 |
| Indicator | ENPH | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 68.18 | 50.13 |
| Support Level | $32.08 | $15.16 |
| Resistance Level | N/A | $16.48 |
| Average True Range (ATR) | 5.97 | 0.43 |
| MACD | 1.87 | -0.00 |
| Stochastic Oscillator | 74.49 | 46.86 |
Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.